Gesynta Pharma

0 followers


Developing unique drug candidates aiming to reduce harmful inflammation and increase blood flow in the body’s microvasculature.

Industries

Headquarters

Employees

Links

Org chart

Patric Stenberg
Co-founder And CEO

Patric Stenberg

Collapse
Michaela Gertz
Chief Financial Officer
Göran Tornling
Chief Medical Officer
Charlotte Edenius
VP, Clinical R&D
Gunilla Ekström
VP, Project Management
Eva Björkstrand
Manager Pharmacology
Sven Sievers
Commercial Manager